Bio-product Molecule Design
and Optimization Platform

Molecule Design Molecule Optimization

Introduction

The AlfaDAX system enables customers to quickly screen and modify protein candidates before they enter the CMC stage, reducing trial and error costs and accelerating the development of new drugs.

Advantages

  • 5 mins
  • 5 mins

    Assessment report

  • 5 days
  • 5 days

    Optimization report

  • Optimized 3 to 1 package
  • Optimized 3 to 1 package

    (Humanization +Affinity +
    Developability)

  • <i>in silico</i> work
  • in silico work

    instead of wet lab work

    Molecule Design

    The predictions showed 100% consistency
    with the final experimental validation.

    Monoclonal Antibody Affnity Increased 29-Fold

  • The predictions showed 100% consistency  <br> with the final experimental validation.
  • Relationship Between Conformation
    and Activity

    Relationship Between Conformation and Activity

  • Relationship Between Conformation <br> and Activity
  • Molecule Optimization

    Affinity Enhancement

    Case1: Monoclonal Antibody
    Affinity Increased 29-Fold

    Case1:Monoclonal Antibody Affinity Increased 29-Fold

  • Case1: Monoclonal Antibody  <br>  Affinity Increased 29-Fold
  • Case2: 43-Fold Affinity Improvement
    with Multi-Metric Validation

    Relationship Between Conformation and Activity

  • Case2: 43-Fold Affinity Improvement <br> with Multi-Metric Validation
  • Case3: Nanobody Affinity Increased
    19.6-Fold

    Case3:Nanobody Affinity Increased 19.6-Fold

  • Case3: Nanobody Affinity Increased   <br>  19.6-Fold
  • Humanization Enhancement

    Case1: Triple Optimization of Monoclonal
    Antibody Humanization

    Case1:Triple Optimization of Monoclonal Antibody Humanization

  • Case1: Triple Optimization of Monoclonal  <br> Antibody Humanization
  • Case2: Breakthrough in Challenging
    Monoclonal Antibody Humanization

    Case2: Breakthrough in Challenging Monoclonal Antibody Humanization

  • Case2: Breakthrough in Challenging  <br> Monoclonal Antibody Humanization
  • Case3: Nanobody Humanization
    Enhancement

    Case3:Nanobody Humanization Enhancement

  • Affinity + Humanization + Developability Optimization

    Case 1: 77-Fold Affinity Improvement with
    Concurrent Functional and Stability Enhancement

    Case 1: 77-Fold Affinity Improvement with Concurrent Functional and Stability Enhancement

  • Case 1: 77-Fold Affinity Improvement with <br> Concurrent Functional and Stability Enhancement
  • Case 2: Nanobody Optimization Achieving
    Both High Affinity and High Humanization
    (94.32% Germline Identity)

    Case 2:Nanobody Optimization Achieving Both High Affinity and High Humanization (94.32% Germline Identity)

  • Case 2: Nanobody Optimization Achieving<br> Both High Affinity and High Humanization <br> (94.32% Germline Identity)
  • Case 3: Multidimensional Optimization of
    a Bispecific Antibody

    Case 3: Multidimensional Optimization of a Bispecific Antibody

  • Case 3: Multidimensional Optimization of  	<br> 	 a Bispecific Antibody
  • Get started with a trail

    Get the Scheme

  • Global Bioprocessing Made Simpler and More Efficient